Sulforaphane Reduces SAMHD1 Phosphorylation To Protect Macrophages from HIV-1 Infection

Area of Science:

• Cellular and Molecular Biology
• Virology
• Immunology

Background:

• SAMHD1 is a crucial protein regulating DNA repair, viral suppression, and immune responses.
• Phosphorylation at Threonine 592 (T592) modulates SAMHD1's diverse functions, including HIV-1 restriction.
• Unphosphorylated SAMHD1 is linked to effective retroviral restriction, independent of its dNTPase activity.

Purpose of the Study:

• To investigate the impact of Nrf2 mobilizers, like Sulforaphane (SFN), on SAMHD1 phosphorylation and HIV-1 restriction in macrophages.
• To explore the mechanisms by which Nrf2 activation influences SAMHD1's antiviral functions.
• To establish Nrf2 pathway activators as a novel approach for studying SAMHD1-mediated virus restriction.

Main Methods:

• Treatment of human monocyte-derived macrophages with Sulforaphane (SFN) and other Nrf2 mobilizers.
• Assessment of SAMHD1 phosphorylation status at T592.
• Evaluation of HIV-1 infection levels in treated and untreated macrophages.
• Analysis of p21 expression and potential redox-dependent mechanisms.

Main Results:

• SFN and other Nrf2 mobilizers significantly reduce SAMHD1 T592 phosphorylation in macrophages.
• Reduced SAMHD1 phosphorylation correlates with enhanced protection against HIV-1 infection.
• SFN, via Nrf2, upregulates p21, contributing to SAMHD1 activation and antiviral defense.
• Evidence suggests a redox-dependent mechanism also contributes to SFN-mediated SAMHD1 activation.

Conclusions:

• Exogenous Nrf2 mobilizers can be used to study virus restriction by SAMHD1.
• The Nrf2 pathway represents a potential therapeutic target for modulating SAMHD1's cellular and antiviral functions.
• Understanding the impact of redox modifiers on SAMHD1 phosphorylation has broad implications for microbiology and therapeutic development.